Company Filing History:
Years Active: 1999-2001
Title: Bernd-Ulrich Von Specht: Innovator in Immunogenic Hybrid Proteins
Introduction
Bernd-Ulrich Von Specht is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunology through his innovative work on hybrid proteins. With a total of two patents to his name, his research focuses on developing solutions to combat infections caused by Pseudomonas aeruginosa.
Latest Patents
His latest patents include the "Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins." This invention relates to a hybrid protein that combines the outer membrane protein I (OprI) with the carboxy-terminal end of the outer membrane protein F (OprF). The hybrid protein, along with monoclonal or polyclonal antibodies against it, provides protection against infections in laboratory animals and humans. Another significant patent is the "Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa." This invention also focuses on the fusion of OprI and OprF, emphasizing the protective capabilities of the hybrid protein and its antibodies against Pseudomonas aeruginosa infections.
Career Highlights
Bernd-Ulrich Von Specht is currently associated with Chiron Behring GmbH & Co., where he continues to advance his research in immunology. His work has been instrumental in developing innovative solutions that address critical health challenges.
Collaborations
He has collaborated with notable colleagues such as Bernhard Knapp and Klaus-Dieter Hungerer, contributing to a dynamic research environment that fosters innovation.
Conclusion
Bernd-Ulrich Von Specht's contributions to the field of immunology through his patents on hybrid proteins highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to improve health outcomes for many.